Precision Medicine for CRC Patients in the Veteran Population: State-of-the-Art, Challenges and Research Directions

Shyam S. Mohapatra, Surinder Kumar Batra, Srinivas Bharadwaj, Michael Bouvet, Bard Cosman, Ajay Goel, Wilma Jogunoori, Michael J. Kelley, Lopa Mishra, Bibhuti Mishra, Subhra Mohapatra, Bhaumik Patel, Joseph R. Pisegna, Jean Pierre Raufman, Shuyun Rao, Hemant Roy, Maren Scheuner, Satish Singh, Gitanjali Vidyarthi, Jon White

Research output: Contribution to journalReview article

4 Citations (Scopus)

Abstract

Colorectal cancer (CRC) accounts for ~9% of all cancers in the Veteran population, a fact which has focused a great deal of the attention of the VA’s research and development efforts. A field-based meeting of CRC experts was convened to discuss both challenges and opportunities in precision medicine for CRC. This group, designated as the VA Colorectal Cancer Cell-genomics Consortium (VA4C), discussed advances in CRC biology, biomarkers, and imaging for early detection and prevention. There was also a discussion of precision treatment involving fluorescence-guided surgery, targeted chemotherapies and immunotherapies, and personalized cancer treatment approaches. The overarching goal was to identify modalities that might ultimately lead to personalized cancer diagnosis and treatment. This review summarizes the findings of this VA field-based meeting, in which much of the current knowledge on CRC prescreening and treatment was discussed. It was concluded that there is a need and an opportunity to identify new targets for both the prevention of CRC and the development of effective therapies for advanced disease. Also, developing methods integrating genomic testing with tumoroid-based clinical drug response might lead to more accurate diagnosis and prognostication and more effective personalized treatment of CRC.

Original languageEnglish (US)
Pages (from-to)1123-1138
Number of pages16
JournalDigestive Diseases and Sciences
Volume63
Issue number5
DOIs
StatePublished - May 1 2018

Fingerprint

Precision Medicine
Veterans
Colorectal Neoplasms
Research
Population
Therapeutics
Neoplasms
Direction compound
Tumor Biomarkers
Genomics
Immunotherapy
Fluorescence
Drug Therapy

Keywords

  • Biomarkers
  • Cancer stem cells
  • Clinical drug response
  • Colorectal cancer
  • FiSS
  • Genomic testing
  • Next generation sequencing
  • Precision Oncology Program (POP)
  • Tumoroids

ASJC Scopus subject areas

  • Physiology
  • Gastroenterology

Cite this

Precision Medicine for CRC Patients in the Veteran Population : State-of-the-Art, Challenges and Research Directions. / Mohapatra, Shyam S.; Batra, Surinder Kumar; Bharadwaj, Srinivas; Bouvet, Michael; Cosman, Bard; Goel, Ajay; Jogunoori, Wilma; Kelley, Michael J.; Mishra, Lopa; Mishra, Bibhuti; Mohapatra, Subhra; Patel, Bhaumik; Pisegna, Joseph R.; Raufman, Jean Pierre; Rao, Shuyun; Roy, Hemant; Scheuner, Maren; Singh, Satish; Vidyarthi, Gitanjali; White, Jon.

In: Digestive Diseases and Sciences, Vol. 63, No. 5, 01.05.2018, p. 1123-1138.

Research output: Contribution to journalReview article

Mohapatra, SS, Batra, SK, Bharadwaj, S, Bouvet, M, Cosman, B, Goel, A, Jogunoori, W, Kelley, MJ, Mishra, L, Mishra, B, Mohapatra, S, Patel, B, Pisegna, JR, Raufman, JP, Rao, S, Roy, H, Scheuner, M, Singh, S, Vidyarthi, G & White, J 2018, 'Precision Medicine for CRC Patients in the Veteran Population: State-of-the-Art, Challenges and Research Directions', Digestive Diseases and Sciences, vol. 63, no. 5, pp. 1123-1138. https://doi.org/10.1007/s10620-018-5000-0
Mohapatra, Shyam S. ; Batra, Surinder Kumar ; Bharadwaj, Srinivas ; Bouvet, Michael ; Cosman, Bard ; Goel, Ajay ; Jogunoori, Wilma ; Kelley, Michael J. ; Mishra, Lopa ; Mishra, Bibhuti ; Mohapatra, Subhra ; Patel, Bhaumik ; Pisegna, Joseph R. ; Raufman, Jean Pierre ; Rao, Shuyun ; Roy, Hemant ; Scheuner, Maren ; Singh, Satish ; Vidyarthi, Gitanjali ; White, Jon. / Precision Medicine for CRC Patients in the Veteran Population : State-of-the-Art, Challenges and Research Directions. In: Digestive Diseases and Sciences. 2018 ; Vol. 63, No. 5. pp. 1123-1138.
@article{9de33f93bdd3405b81375f76650f4f14,
title = "Precision Medicine for CRC Patients in the Veteran Population: State-of-the-Art, Challenges and Research Directions",
abstract = "Colorectal cancer (CRC) accounts for ~9{\%} of all cancers in the Veteran population, a fact which has focused a great deal of the attention of the VA’s research and development efforts. A field-based meeting of CRC experts was convened to discuss both challenges and opportunities in precision medicine for CRC. This group, designated as the VA Colorectal Cancer Cell-genomics Consortium (VA4C), discussed advances in CRC biology, biomarkers, and imaging for early detection and prevention. There was also a discussion of precision treatment involving fluorescence-guided surgery, targeted chemotherapies and immunotherapies, and personalized cancer treatment approaches. The overarching goal was to identify modalities that might ultimately lead to personalized cancer diagnosis and treatment. This review summarizes the findings of this VA field-based meeting, in which much of the current knowledge on CRC prescreening and treatment was discussed. It was concluded that there is a need and an opportunity to identify new targets for both the prevention of CRC and the development of effective therapies for advanced disease. Also, developing methods integrating genomic testing with tumoroid-based clinical drug response might lead to more accurate diagnosis and prognostication and more effective personalized treatment of CRC.",
keywords = "Biomarkers, Cancer stem cells, Clinical drug response, Colorectal cancer, FiSS, Genomic testing, Next generation sequencing, Precision Oncology Program (POP), Tumoroids",
author = "Mohapatra, {Shyam S.} and Batra, {Surinder Kumar} and Srinivas Bharadwaj and Michael Bouvet and Bard Cosman and Ajay Goel and Wilma Jogunoori and Kelley, {Michael J.} and Lopa Mishra and Bibhuti Mishra and Subhra Mohapatra and Bhaumik Patel and Pisegna, {Joseph R.} and Raufman, {Jean Pierre} and Shuyun Rao and Hemant Roy and Maren Scheuner and Satish Singh and Gitanjali Vidyarthi and Jon White",
year = "2018",
month = "5",
day = "1",
doi = "10.1007/s10620-018-5000-0",
language = "English (US)",
volume = "63",
pages = "1123--1138",
journal = "Digestive Diseases and Sciences",
issn = "0163-2116",
publisher = "Springer New York",
number = "5",

}

TY - JOUR

T1 - Precision Medicine for CRC Patients in the Veteran Population

T2 - State-of-the-Art, Challenges and Research Directions

AU - Mohapatra, Shyam S.

AU - Batra, Surinder Kumar

AU - Bharadwaj, Srinivas

AU - Bouvet, Michael

AU - Cosman, Bard

AU - Goel, Ajay

AU - Jogunoori, Wilma

AU - Kelley, Michael J.

AU - Mishra, Lopa

AU - Mishra, Bibhuti

AU - Mohapatra, Subhra

AU - Patel, Bhaumik

AU - Pisegna, Joseph R.

AU - Raufman, Jean Pierre

AU - Rao, Shuyun

AU - Roy, Hemant

AU - Scheuner, Maren

AU - Singh, Satish

AU - Vidyarthi, Gitanjali

AU - White, Jon

PY - 2018/5/1

Y1 - 2018/5/1

N2 - Colorectal cancer (CRC) accounts for ~9% of all cancers in the Veteran population, a fact which has focused a great deal of the attention of the VA’s research and development efforts. A field-based meeting of CRC experts was convened to discuss both challenges and opportunities in precision medicine for CRC. This group, designated as the VA Colorectal Cancer Cell-genomics Consortium (VA4C), discussed advances in CRC biology, biomarkers, and imaging for early detection and prevention. There was also a discussion of precision treatment involving fluorescence-guided surgery, targeted chemotherapies and immunotherapies, and personalized cancer treatment approaches. The overarching goal was to identify modalities that might ultimately lead to personalized cancer diagnosis and treatment. This review summarizes the findings of this VA field-based meeting, in which much of the current knowledge on CRC prescreening and treatment was discussed. It was concluded that there is a need and an opportunity to identify new targets for both the prevention of CRC and the development of effective therapies for advanced disease. Also, developing methods integrating genomic testing with tumoroid-based clinical drug response might lead to more accurate diagnosis and prognostication and more effective personalized treatment of CRC.

AB - Colorectal cancer (CRC) accounts for ~9% of all cancers in the Veteran population, a fact which has focused a great deal of the attention of the VA’s research and development efforts. A field-based meeting of CRC experts was convened to discuss both challenges and opportunities in precision medicine for CRC. This group, designated as the VA Colorectal Cancer Cell-genomics Consortium (VA4C), discussed advances in CRC biology, biomarkers, and imaging for early detection and prevention. There was also a discussion of precision treatment involving fluorescence-guided surgery, targeted chemotherapies and immunotherapies, and personalized cancer treatment approaches. The overarching goal was to identify modalities that might ultimately lead to personalized cancer diagnosis and treatment. This review summarizes the findings of this VA field-based meeting, in which much of the current knowledge on CRC prescreening and treatment was discussed. It was concluded that there is a need and an opportunity to identify new targets for both the prevention of CRC and the development of effective therapies for advanced disease. Also, developing methods integrating genomic testing with tumoroid-based clinical drug response might lead to more accurate diagnosis and prognostication and more effective personalized treatment of CRC.

KW - Biomarkers

KW - Cancer stem cells

KW - Clinical drug response

KW - Colorectal cancer

KW - FiSS

KW - Genomic testing

KW - Next generation sequencing

KW - Precision Oncology Program (POP)

KW - Tumoroids

UR - http://www.scopus.com/inward/record.url?scp=85044377881&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85044377881&partnerID=8YFLogxK

U2 - 10.1007/s10620-018-5000-0

DO - 10.1007/s10620-018-5000-0

M3 - Review article

C2 - 29572615

AN - SCOPUS:85044377881

VL - 63

SP - 1123

EP - 1138

JO - Digestive Diseases and Sciences

JF - Digestive Diseases and Sciences

SN - 0163-2116

IS - 5

ER -